HC Wainwright Boosts Earnings Estimates for COMPASS Pathways

COMPASS Pathways plc (NASDAQ:CMPS) – HC Wainwright lifted their Q1 2025 EPS estimates for shares of COMPASS Pathways in a report released on Thursday, February 13th. HC Wainwright analyst P. Trucchio now forecasts that the company will earn ($0.34) per share for the quarter, up from their previous forecast of ($0.51). HC Wainwright currently has a “Buy” rating and a $45.00 price objective on the stock. The consensus estimate for COMPASS Pathways’ current full-year earnings is ($2.33) per share. HC Wainwright also issued estimates for COMPASS Pathways’ Q2 2025 earnings at ($0.34) EPS, Q3 2025 earnings at ($0.32) EPS, Q4 2025 earnings at ($0.30) EPS, FY2025 earnings at ($1.29) EPS, FY2026 earnings at ($1.38) EPS and FY2027 earnings at ($0.92) EPS.

Several other research analysts also recently commented on the stock. Royal Bank of Canada reissued an “outperform” rating and set a $18.00 price objective on shares of COMPASS Pathways in a report on Wednesday, January 15th. Maxim Group lowered their price target on shares of COMPASS Pathways from $22.00 to $12.00 and set a “buy” rating for the company in a report on Friday, November 1st. Six research analysts have rated the stock with a buy rating, According to MarketBeat.com, COMPASS Pathways has an average rating of “Buy” and an average target price of $30.60.

COMPASS Pathways Stock Down 2.9 %

CMPS opened at $4.44 on Monday. The firm has a 50-day simple moving average of $4.09 and a two-hundred day simple moving average of $5.40. COMPASS Pathways has a 52 week low of $3.16 and a 52 week high of $12.75. The company has a market capitalization of $303.58 million, a PE ratio of -2.02 and a beta of 2.28. The company has a quick ratio of 8.91, a current ratio of 8.91 and a debt-to-equity ratio of 0.15.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Polar Asset Management Partners Inc. lifted its holdings in shares of COMPASS Pathways by 83.3% in the 3rd quarter. Polar Asset Management Partners Inc. now owns 567,600 shares of the company’s stock valued at $3,576,000 after acquiring an additional 258,000 shares during the last quarter. Sio Capital Management LLC boosted its position in shares of COMPASS Pathways by 211.7% during the third quarter. Sio Capital Management LLC now owns 914,639 shares of the company’s stock valued at $5,762,000 after buying an additional 621,222 shares during the period. Walleye Capital LLC purchased a new position in shares of COMPASS Pathways during the third quarter valued at approximately $2,126,000. Acuta Capital Partners LLC purchased a new position in shares of COMPASS Pathways during the third quarter valued at approximately $2,435,000. Finally, Geode Capital Management LLC boosted its position in shares of COMPASS Pathways by 160.3% during the third quarter. Geode Capital Management LLC now owns 42,169 shares of the company’s stock valued at $266,000 after buying an additional 25,970 shares during the period. Institutional investors own 46.19% of the company’s stock.

COMPASS Pathways Company Profile

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa.